2025 Speakers
Alex Sia has been CEO of KKH since 2017, transforming it into a leading global Academic Medical Centre for women and children’s health. Under his leadership, KKH established the Maternal and Child Health Research Institute, boosting research, clinical care, and international collaborations. In 2024, KKH ranked 9th among Asia-Pacific’s Best Children’s Hospitals and 30th in Singapore’s Best Employers list. Alex holds three patents, co-founded med-tech startups, and developed groundbreaking medical technologies. He is a top-ranked researcher in obstetric anesthesia, recognized globally for his influential contributions to pain management and innovation.
Prof Alex Sia
Chief Executive Officer
CEO’s Office
KK Women’s & Children’s Hospital
Dr. Alexander Jarasch is Neo4j’s global Head for Pharma & Life Sciences at Neo4j. He holds a PhD in bioinformatics, and a 20-year career that spans chemistry, biotech, pharma, and IT. Dr Jarasch has received numerous awards for innovative analytics techniques such as knowledge graphs to combat diseases such as diabetes. Prior to Neo4j, Dr Jarasch was the Head of Data and Knowledge Management at the German Center for Diabetes Research (DZD), following prior roles at Roche Diagnostics, Max Planck Institute for Biochemistry. His current work has him at the forefront of AI and Life Sciences and specifically using knowledge graphs and GenAI for target identification, competitive intelligence, anti-counterfeiting of drugs, and other use cases. He speaks frequently at major healthcare conferences and his published articles can be found in journals such as SCIENCE, PNAS, NSMB and Bioinformatics.
Dr Alexander Jarasch
Global Head of Pharma and Life Sciences
Pharma and Life Sciences
Neo4j
Mr Alexis Lee
Commercial Lead, Singapore & RoASEAN
AMD
Alexis is Commercial Sales Lead for Singapore & RoASEAN in AMD, responsible for Data Center Solutions (Computer & GPU), Commercial Client PC – driving revenue and strategic engagements with end-user customers, OEMs/ODMs and channel partners. Alexis brings with him 25 years’ experience in the areas of starting businesses, product management, solution selling, marketing and business development within the APAC & North America markets. He is highly experienced in collaborating with customers, global partners and business stakeholders to achieve revenue goals and develop alliance partnerships in business environments across industries from consumer, services to IT digitalization. He has also been involved as contributor in IMDA Green IT Technical Committee and Energy Efficiency of Data Centre IT equipment Workgroup.
Mr Alexis Lee
Commercial Lead, Singapore & RoASEAN
AMD
Alfonsius P. Timboel is the Chief Operating Officer at Halodoc, where he drives operational excellence and strategic growth in the health tech sector. With over 20 years of experience spanning operations, business development, and product management, he specializes in identifying key challenges, structuring solutions, and leveraging product and data-driven insights. Passionate about innovation, he focuses on integrating AI and technology to enhance healthcare accessibility and efficiency. His expertise includes strategic planning, corporate leadership, and optimizing business and product strategies in dynamic, fast-paced environments.
Mr Alfonsius P Timboel
Chief Operating Officer
Halodoc
Dr Andrew Wu is a healthtech innovator and startup leader with more than 20 years experience in commercialising biomedical technologies. He is the Co-Founder and CEO of Mesh Bio, a pioneering deep healthtech startup focused on providing predictive analytics solutions, based on foundational digital twin models, for chronic disease diagnosis and management. Prior to founding Mesh Bio, Andrew held leadership roles in various clinical laboratory services and in vitro diagnostics startups, which successfully went public. He started his career as a bioprocess engineer in the CDMO industry. Andrew holds a Bachelors and PhD in Biochemical Engineering from University College London.
Dr Andrew Wu
Co-Founder & Chief Executive Officer
Mesh Bio
Annie Ong, General Manager at ST Engineering, leads the global sales team for Enterprise Digital, focusing on healthcare, financial services, and key industries. With over 25 years of experience, Annie has led significant business growth in AI and digital transformation. She has held senior roles at ChainUp, OneConnect, Salesforce, Oracle, and IBM, excelling in innovation and consultative selling. Annie’s commitment to innovation and customer-centric solutions has established her as a trusted advisor to executives of large enterprises. Her focus on delivering disruptive digital business transformation solutions underscores her dedication to advancing technology and meeting the evolving needs of her clients.
Ms Annie Ong
General Manager
Enterprise Digital
ST Engineering
Professor Aymeric Lim is the CEO of Singapore’s National University Hospital (NUH), a 1,250-bed teaching hospital. He’s also a Senior Consultant in Hand & Reconstructive Microsurgery and a Professor of Orthopaedic Surgery. Aymeric has held numerous leadership positions in healthcare and the military. Under his leadership, NUH adopted a digital-first strategy, implementing AI-based neuroimaging and real-time data dashboards. He’s received accolades including a Public Administration Medal (Gold) for his work during COVID-19. An internationally recognized hand and reconstructive microsurgeon, Aymeric specializes in peripheral nerve surgery and has led medical missions to various countries. His research has contributed to innovations in tendon and nerve transfers.
Prof Aymeric Lim
Chief Executive Officer
National University Hospital
Dr. Brian Anderson is the CEO of the Coalition for Health AI (CHAI), a non-profit coalition he co-founded in 2021. CHAI is focused on developing a set of consensus-driven guidelines and best practices for Responsible AI in Health, as well as supporting the ability to independently test and validate AI for safety and effectiveness .Prior to CHAI, Dr. Anderson was the Chief Digital Health Physician at MITRE where he led research and development efforts across major strategic initiatives in Digital Health, including partnering with the United States Government and private sector organizations. He was also the co-PI on MITRE’s largest Health R&D effort in Oncology, supporting the Biden Administration’s Cancer Moonshot effort.
Dr Brian Anderson
Chief Executive Officer
Executive Leadership
Coalition for Health AI, Inc. (CHAI)
Ms Caroline Yap
Founder
AISHA
(AI Strategies for Human Advancement)
Ex-Google AI
Pioneer in leveraging AI/ML for enterprise transformation and ethical technology advocacy. As the Managing Director, Global AI Business and Applied Engineering at Google Cloud, Caroline leads a team of AI leaders who help enterprise clients and customers harness the power of AI/ML technologies to extract insights from their data and create value for their businesses. She has over 25 years experience in technology, with a strong background in applied infrastructure across networking, security, and cloud. Caroline also advises government, policy makers, and think tanks on responsible innovation with AI, drawing from her expertise in AI strategy, ethics, and governance. She is and has served as board advisor to private companies and non-profits.
Ms Caroline Yap
Founder
AISHA
(AI Strategies for Human Advancement)
Ex-Google AI
Dr Charlie Lee is the Genomics Industry Lead for APJ at AWS, with over 20 years of experience spanning research and industry. He started his career at the Genome Institute of Singapore where he pioneered pathogen detection technologies during the SARS and H1N1 outbreaks. In the industry, Dr Lee held senior roles at Vela Diagnostics, leading a team to develop and launch over 40 molecular diagnostic products, including the first CE-IVD NGS-based oncology test and the first FDA-approved NGS-based HIV genotyping test. Dr Lee also contributed to an award-winning genomics health platform at Human Longevity Inc, a genomics health intelligence company. At AWS, Dr Lee drives genomics strategies and engagements across APJ, supporting precision medicine initiatives and leveraging cloud and AI to accelerate innovation in healthcare and improve patient outcomes.
Dr Charlie Lee
Genomics Industry Lead, APJ
Amazon Web Services
Dr. Cheng is Head and Senior Consultant for Department of Anatomical Pathology in Singapore General Hospital (SGH), with special interest in haematolymphoid pathology and healthcare informatics. He is also Director of Computational and Digital Pathology under Division of Pathology in SGH. He is actively involved in the implementation and roll out of the digital pathology system in SGH and his current role has extended beyond digital pathology to cover various aspects of pathology informatics, including use and adoption of analytics, data science and artificial intelligence. He also had previous experience with implementation of National electronic health record program and several other health information technology enablement projects and programs through his previous role in public service related agencies.
Dr Cheng Chee Leong
Head
Anatomical Pathology
Singapore General Hospital
Wai Chiew has over 25 years of experience in global investment management and strategic business development, having been active in leading various companies on transformational growth strategies, fundraising and M&A. In his previous roles at Temasek and most recently as CEO & Executive Director of Heritas Capital, he has led and managed VC / PE / Fund-of Funds and impact investments across multiple industries and geographies, deploying capital for institutions as well as multiple family offices into innovative businesses and deep tech ventures, including many AI-enabled category leaders in healthcare.
Mr Chik Wai Chiew
Founder
Skysurfer Consulting
Dr. Chris Fang is a physician-entrepreneur with 20+ years of global experience spanning clinical development, digital transformation, and business development across biopharma, healthtech, and medtech. Currently the Chief Commercial Officer at Hippocratic AI, he drives go-to-market activities for pharma, life sciences and International. Chris has held senior roles at Eli Lilly, IQVIA, Medtronic, and Johnson & Johnson, where he pioneered digital transformation, spearheaded clinical research and global medical affairs. He co-founded Acer Health with Stan Shih to advance AI and big data in healthcare. Dr. Fang holds an MBA from The Wharton School, an MD from Cornell University Weill Medical College, a Master of Health Science from Johns Hopkins School of Public Health, with fellowship training in medical informatics from Massachusetts General Hospital.
Dr Chris Fang
Chief Commercial Officer
Pharma & Life Sciences
Hippocratic AI
Chris Haddad is a results-driven machine learning specialist with 9 years of experience in healthcare. He has worked on projects including predictive analytics, payer life science work, full-stack data science development, and generative AI. He began his career as a machine learning engineer at a large electronic health records company. He developed algorithms to predict patient risk of readmission, identify high-cost patients, and optimize clinical workflows. In his most recent role at McKinsey & Company, he led a team of machine learning engineers in developing and deploying predictive models that saved healthcare payers millions of dollars. Chris is now a Senior Health ML Solutions Architect at Amazon Web Services, where he helps healthcare companies adopt generative AI.
Mr Chris Haddad
Machine Learning Solutions Architect
Global Health
Amazon Web Services
Chris Tan is a seasoned IT professional with over 15 years of experience across the APAC region. He has deep domain expertise in GPU, Cloud, Cybersecurity, and Digital Twin technologies. As a technical evangelist, Chris has been at the forefront of GPU adoption, from its early use in Data Science to its pivotal role in today’s AI revolution. In his current role at Singtel RE:AI GPU Cloud, a sovereign GPU cloud provider, Chris is focused on enabling AI adoption across enterprises and state government bodies. His expertise helps organizations navigate the complexities of AI infrastructure, ensuring secure, scalable, and efficient deployment yielding productive innovation
Mr Chris Tan
Head of Sales
GPU Cloud
Singtel
Assoc Prof Melvin Chua Lee Kiang
Director
Data and Computational Science Core
National Cancer Centre Singapore
Dr Chua is a Clinician-Scientist at the NCCS and Duke-NUS Medical School, and Principal Investigator of the Precision Radiotherapeutics and Oncology Programme, Division of Medical Sciences, supported by the NMRC Clinician-Scientist Award. He is also the Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers, Division of Radiation Oncology, and Director of the Data and Computational Science Hub at the NCCS. He has obtained more than 70 million dollars in research funding, and his research focuses on the development of Phase II-III clinical trials in nasopharyngeal (NPC) and prostate cancers. He also runs a laboratory that is involved in data science and omics analytics that help with therapeutic and biomarker discovery for these cancer types. He is jointly appointed as an Associate Professor (On Tenure) with the Duke-NUS Medical School, Singapore.
Assoc Prof Melvin Chua Lee Kiang
Director
Data and Computational Science Core
National Cancer Centre Singapore
Colin is the Chief Information Officer and Chief Data Officer of the Singapore Ministry of Health. He is also Group Director, InfoComm, Technology and Data Group. Prior to MOH, he was the founder and CEO of mobilityX, a start-up that received funding from SMRT and Toyota Tsusho. His previous experience includes the private (IBM UK and SMRT) and public (Singapore Administrative Service – Ministries of Home Affairs, Manpower and Transport as well as the Land Transport Authority) sectors. He graduated from the London School of Economics and Oxford University, and has
Mr Colin Lim
Chief Information Officer & Chief Data Officer
Ministry of Health, Singapore
Dr. Langlotz is Professor of Radiology, Medicine, and Biomedical Data Science, and Senior Associate Vice Provost for Research at Stanford University. He also serves as Director of the Center for Artificial Intelligence in Medicine and Imaging (AIMI Center), which comprises over 150 faculty at Stanford who conduct interdisciplinary machine learning research to promote health. Dr. Langlotz’s laboratory develops machine learning methods to detect disease and eliminate diagnostic errors. He has led many national and international efforts to improve medical imaging, including the RadLex terminology standard and the Medical Imaging and Data Resource Center (MIDRC), a U.S. national imaging research resource.
Prof Curtis Langlotz
Senior Associate Vice Provost
Research
Stanford University
Dr. Blezek is an AI Scientist in the Department of Radiology, Mayo Clinic. He has been involved in the development and clinical implementation of multiple AI algorithms for detection, segmentation and enhancement of medical images. He has a focus on development, regulatory verification and validation of AI algorithms.
Dr Daniel Blezek
AI Scientist
Radiology
Mayo Clinic
Dr. Daniel Ting is an Associate Professor at Duke-NUS Medical School and Stanford University, senior consultant vitreo-retinal surgeon at the Singapore National Eye Centre, Director of SingHealth AI Office, and on the Lancet Digital Health International Advisory Board. A/Prof Ting has >300 publications in top journals like JAMA, NEJM, and Nature Medicine and serves on global AI executive committees: STARD-AI, QUADAS-AI, and DECIDE-AI.
Published in 2023, his Nature Medicine paper, entitled Large Language Model in Medicine, has scored >2000 citations to date. He also secured $100M health grants for AI and digital innovation related project. In 2024, he received the President’s Singapore National Academy of Science Young Scientist Award.
A/Prof Ting is ranked the 2024 Top 100 AI Power List (with Fei Fei Li, Yan LeCun, Jensen Huang and others), Top 100 Ophthalmologists Power List and Stanford University World’s Top 2% Scientists over the past 4 years (2021 till 2025). In ExpertScape, he is also ranked top 3 deep learning AI researchers among >150k researchers worldwide for the past 15 years (2010-2024).
Assoc Prof Daniel Ting
Director
AI Office
SingHealth
Dr Danny Belkin, PhD MBA is the Director of the SingHealth Technology Incubator (SCOUT). He holds a Ph.D. in Immunology from the University of Cambridge, UK and an MBA from Vlerick Leuven Management School in Belgium. Dr Belkin was previously the Technology Development and Commercialization Director of the Singapore Eye Research Institute (SERI), where he successfully led efforts to create enduring strategic industrial collaborations with MNCs, led creation of a number of spinoff companies and licensing a large number of technologies to private sector partners. Dr Belkin has over 20 years of wide-ranging experience in the biomedical industry, having been part of the founding team of a stem cell therapy startup as well as having held strategic marketing and special projects management roles at Abbott Labs, before joining SERI and SingHealth.
Dr Danny Belkin
Director
SingHealth Technology Incubator (SCOUT)
SingHealth
Assoc Prof Danny Soon
Chief Executive Officer
Consortium for Clinical Research and Innovation Singapore
A/Prof Danny Soon is Chief Executive Officer at the Consortium for Clinical Research and Innovation, Singapore (CRIS), and concurrent Executive Director at the Singapore Clinical Research Institute (SCRI). As the CEO of CRIS, Danny has the responsibility of bringing together five research programmes and platforms under the auspices of CRIS, promulgating synergies and strategies, building corporate functions to service the entire entity. He has a long experience in drug development, having worked at Eli Lilly for 15 yrs, where he headed up the Lilly-NUS Centre for Clinical Pharmacology (LNUS). As the Managing Director & Principal Investigator, he had responsibility and oversight for all clinical Phase 1 studies conducted and operations in the unit. Danny was previously the Executive Director at BMRC, A*STAR & founding CEO of the Experimental Biotherapeutics Centre.
Assoc Prof Danny Soon
Chief Executive Officer
Consortium for Clinical Research and Innovation Singapore
As hold positions as the co-founder and Chief Data and Technology Officer at Galen Growth, co-founder & Interim CEO at Enigma Health, and Industrial Liason Commercial Officer at SingHealth. Dario built HealthTech Alpha, the leading digital health venture data aggregator to support innovators and led hundreds of strategy projects for pharmaceuticals, insurance, and governments globally.
Dr Dario Heymann
Co-Founder & Chief Data & Technology Officer
Galen Growth
DR Darius M. Moshfeghi
Chief of Retina
Ophthalmology, Byers Eye Institute
Stanford University School of Medicine
Darius M. Moshfeghi, MD, is Chief of Retina at Stanford University School of Medicine He created the largest telemedicine program in ophthalmology for premature and term infants, providing screening coverage for >2.5% of USA hospitals and >4% of eligible infants. He is a director for GigCapital7 (GIGGU). He sold Placid0 to Waldo and was instrumental as a director when KKR acquired 1800 Contacts. He co-founded Vision Labs, a mobile corneal screening technology, and Pr3vent, which offers universal newborn eye screening of infants on 3 continents. Dr. Moshfeghi was inducted into the 2021 class of the Retina Hall of Fame.
Dr Darius M. Moshfeghi
Chief of Retina
Ophthalmology, Byers Eye Institute
Stanford University School of Medicine
Mr David Vu is Program Director for Singapore’s Biomedical Data Hub (BDH), hosted at A*STAR. BDH curates and maintains strategic health data cohorts and supports researchers and innovators with expertise in bioinformatics and AI. Prior to joining BDH, David was Chief Operating Officer at DxD Hub where he founded the Digital Health Accelerator and at ST Engineering where he worked on MedTech M&A. He also has 20 years with GE HealthCare including a role as VP for Healthcare Digital Solutions in Asia. In this role he led a business team responsible for clinical workflow solutions deployed in Asia’s premier hospitals.
Mr David Vu
Program Director
Singapore Biomedical Data Hub
A*STAR
Prof. Ho and team also manage a portfolio of over 10 prospective, interventional human oncology clinical trials with life-saving outcomes. A serial entrepreneur, he has advised health/human performance teams, nutrition and wearable firms, and venture funds on digital medicine deployment. Prof. Ho is an elected Fellow of the US National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the Royal Society of Chemistry. Prof. Ho is Co-Chair of the World Health Organization (WHO) Working Group for the regulation of AI for Health.
Prof Dean Ho
Director
The Institute for Digital Medicine (WisDM)
National University of Singapore
Ms Denise Wong
Assistant Chief Executive
Data Innovation and Protection Group
Infocomm Media Development Authority
Assistant Chief Executive (Data Innovation & Protection Group,) Infocomm Media Development Authority (IMDA), Singapore and Deputy Commissioner, Personal Data Protection Commission (PDPC), Singapore. As Assistant Chief Executive (Data Innovation & Protection Group) at IMDA, Denise’s scope of work includes developing forward-thinking governance on AI and data, driving a pipeline of AI talent, promoting industry adoption of AI, as well as building specific AI and data science capabilities in Singapore. In her capacity as Deputy Commissioner of the PDPC, Denise oversees the administration and enforcement of the Personal Data Protection Act (2012). Her key responsibilities include managing the formulation and implementation of policies relating to the protection of personal data, as well as issuing of enforcement directions for organisational actions.
Ms Denise Wong
Assistant Chief Executive
Data Innovation and Protection Group
Infocomm Media Development Authority
Dinggang Shen, PhD is a Professor and a Founding Dean with School of Biomedical Engineering, ShanghaiTech University, and also a Co-CEO of United Imaging Intelligence (UII), China. He is a Fellow of IEEE, AIMBE, IAPR, MICCAI, ISMRM, and IAMBE. He was a recipient of Technical Achievement Award from IEEE EMBS (2024). He was also a Full Professor (Tenured) with UNC Chapel Hill, a tenure-track assistant professor in UPenn, and an Instructor in Johns Hopkins University, USA. His research interests include medical image analysis and artificial intelligence, in which he published >1,500 peer-reviewed papers, with H-index 153 and 98000+ citations. He serves as Editor-in-Chief for Frontiers in Radiology, Senior Editor for Medical Image Analysis, Senior Editor for IEEE TBME, and editorial board member for six international journals. He was the General Chair for MICCAI 2019.
Prof Dinggang Shen
Founding Dean
School of Biomedical Engineering
ShanghaiTech University
Dmitry Pavlov works over 30 years in Medical Imaging. He started his career developing software for scanners. Working for leading healthcare companies he designed and built PACS and VNA systems. Dmitry is He is an inventor on issued U.S. patents in medical imaging. He was co-founder of two startups. Currently he works for Amazon Web Services (AWS) as Global Medical Imaging Technical Lead. In this role Dmitry helps healthcare providers and healthcare software vendors to adopt new cloud technologies and leapfrog into the future with unlimited scalability, fast application performance, and AI-assisted workflows.
Mr Dmitry Pavlov
Global Medical Imaging Technical Lead
Global Health
Amazon Web Services
Senior Principal Analyst in Machine Learning at SingHealth with over 15 years of experience in AI, data science, and technology leadership. Previously served as a Senior AI Scientist at the Urban Redevelopment Authority of Singapore (URA) and Lead Research Scientist at fintech and genomics startups, where she led research and development teams in the design of intelligent systems for compliance, risk management, and e-commerce solutions. Expertise includes machine learning, deep neural networks. She holds a PhD in Computer, Communication and Information Sciences from Swiss Federal Institute of Technology Lausanne, specializing in Brain-Computer Interfaces.
Dr Eileen Lew
Senior Principal Analyst
Office of Insights and Analytics
SingHealth
Assoc Prof Eric Wong
Group Chief Digital Health Officer
Group Digital Health Office
National Healthcare Group
A/Prof Eric Wong is the Group Chief Digital Health Officer (GCDHO) with the National HealthCare Group (NHG), and a Senior Consultant at Tan Tock Seng Hospital. Prior to his appointment as GCDHO, he was the Group Chief Clinical Informatics Officer (GCCIO) at NHG, where he was responsible for the overall vision, planning and implementation of its healthcare IT capabilities, as well as the Chief Medical Informatics Officer (CMIO) at TTSH. Over his tenue he was responsible for NGEMR implementation in NHG, NHG Care mobile apps, development of CPSS2 etc, and represented NHG in various MOH IT initiatives including NEHR, HIM Policy formulation, HITMAP2.0 among others.
Assoc Prof Eric Wong
Group Chief Digital Health Officer
Group Digital Health Office
National Healthcare Group
Prof Ernst Kuipers
Vice President (Research)
President’s Office
Nanyang Technological University Singapore
Ernst Kuipers is Vice President (Research) at Nanyang Technology University, Singapore. He earlier served as Minister of Health, Welfare and Sport of the Netherlands. He was also a member of the Governing Board of the National University Health System in Singapore, and a member of the Board of Curaçao Medical Center. Professor Kuipers is a Fellow of the American Gastroenterological Association, Honorary Member of the European Helicobacter & Microbiota Study Group, and an Honorary Fellow of the Hong Kong Society of Gastroenterology. An esteemed scholar, Professor Kuipers is the recipient of many awards, including the Dutch Ministry of Health Pearl Award and the Influencer of the Year Award in Hospital Healthcare.
Prof Ernst Kuipers
Vice President (Research)
President’s Office
Nanyang Technological University Singapore
Dr Fidah Alsagoff
Joint Head, Enterprise Development Group (Singapore) & Head, Life Sciences
Temasek International
Dr Fidah Alsagoff is Joint Head, Enterprise Development Group (Singapore) & Head of Life Sciences Investment Group at Temasek International. He also serves on the Board of Trustees of the Singapore University of Technology & Design, and the Duke-NUS Medical School.
Fidah has an M.B.B.S. and Masters of Medicine (Public Health) from NUS. He also graduated as valedictorian from INSEAD with an Executive Masters of Business Administration (with Distinction). He is a recipient of the Lee Kuan Yew Scholarship.
Dr Fidah Alsagoff
Vice Chairman, Healthcare and Life Sciences (Global Partnerships)
Temasek International
Assoc Prof Gavin Tan
Head & Senior Consultant
Surgical Retina
Singapore National Eye Centre
Associate Professor Gavin Tan is the Vice Chair for Strategy, Innovation, and Organisational Transformation; Clinical Director for SNEC Ocular Reading Centre (SORC) and the Head of the Ocular Diagnostics Department at Singapore National Eye Centre. Dr Tan played a key role in developing and implementing Singapore’s National Diabetic Retinopathy Telemedicine Screening Program, where AI was developed for detecting diabetic retinopathy and successfully translated into clinical practice. His primary research focus is diabetic eye disease and using the eye as a window to diabetic complications. He has also developed telemedicine-based virtual imaging clinics and various digital solutions to enhance patient care.
Assoc Prof Gavin Tan
Head & Senior Consultant
Surgical Retina
Singapore National Eye Centre
Prof Haibo Wang
Director
Research Centre of Big Data and Artificial Intelligence for Medicine, First Affiliated Hospital of Sun Yat-Sen University
Professor Haibo Wang is the Director for Research Centre of Big Data and Artificial Intelligence for Medicine, First Affiliated Hospital of Sun Yat-sen University; and the executive Editor-in-Chief of Health Care Science, Institute for Hospital Management of Tsinghua University. Professor Wang’s research focus on the intersection of data science and artificial intelligence in medicine. He has published more than 100 SCI publications including prestigious international journals such as NEJM, Lancet, BMJ, NEJM AI and Lancet Digital Health.
Prof Haibo Wang
Director
Research Centre of Big Data and Artificial Intelligence for Medicine, First Affiliated Hospital of Sun Yat-Sen University
Assoc Prof Hairil Rizal Abdullah
Senior Consultant & Clinician Scientist
Anaesthesiology
Singapore General Hospital
Assoc Prof Hairil Abdullah MBBS MMed MSc PhD, is a Senior Consultant Anesthesiologist at SGH. He revolutionized patient preparation for surgeries in SGH by founding the Perioperative Medicine service and its Preoperative Assessment Centre in 2014. His leadership in developing various programs like Patient Blood Management and Prehabilitation Service has garnered both national and international recognition. Honoured with Singapore’s prestigious Lee Kuan Yew Scholarship in 2022 and listed among the top 2% of globally cited scientists, Hairil currently leads the Value Based Healthcare initiatives in both Singapore General Hospital and the wider SingHealth healthcare cluster. He was awarded the “Distinguished Champion of Change Leader Award” by SingHealth in 2022 for his transformative contributions to healthcare
Assoc Prof Hairil Rizal Abdullah
Senior Consultant & Clinician Scientist
Anaesthesiology
Singapore General Hospital
Harvey Castro, MD, is a pioneering leader in healthcare and artificial intelligence. He owns and directs innovative developments at his AI company, Castro AI. In 2022, he authored the influential book ChatGPT and Healthcare, which explores the transformative impact of AI on medicine. As an advisor for the Singapore Government and the Texas Medical Association, Dr. Castro actively guides advancements in AI healthcare policy and integration, emphasizing technology’s role in enhancing patient outcomes and operational efficiency in medical settings.
Dr Harvey Castro
Chief Medical AI Officer
Executive Leadership
Helpp.ai
A/Prof Henry Ho is the Chairman, Division of Surgery and Surgical Oncology In Singapore General
Hospital & National Cancer Center; Chairman of Surgery Academic Clinical Program, Singhealth
DUKE-NUS. In addition to overseeing the surgeons’ practice and professional development, clinical
operational productivity is another important area of his responsibility.
He is also the Executive Director of National Healthcare Innovation Center (NHIC) that is marking its
its 10 years anniversary in 2024, in supporting innovation , commercialisation, adoption and
transformation for healthcare in Singapore.
He started his innovation journey with Mona Lisa, a device for accurate and safer prostate biopsy
for cancer diagnosis. The start-up has raised series B funding and is used in Germany, Italy and
Australia. As the inaugural graduate scholar of the Singapore – Stanford Biodesign programme, he
formulated the singhealth innovation ecosystem and launched several initiatives such as from
Medical Technology Office to Alice Lee Innovation Center of Excellence (A.L.I.C.E.)
As a senior Urologist consultant in SGH, he specializes in robotic surgery in prostate and kidney
cancer. In benign prostate enlargement; which is a common chronic disease in elderly men. He also
wishes to connect the urologist to primary care doctor to better triage its appropriate care. This is
done though a plethora of innovation, training and clinical protocol co-creation.
Assoc Prof Henry Ho
Executive Director
National Healthcare Innovation Center
Dr. Hsien-Hsien Lei is Chief Executive Officer (CEO) of The American Chamber of Commerce (AmCham) in Singapore — the largest and the most active international business association in Singapore and Southeast Asia representing nearly 700 companies. Hsien is also Adjunct Associate Professor at the National University of Singapore Saw Swee Hock School of Public Health, member of the Johns Hopkins University Bloomberg School of Public Health’s Advisory Board, Vice President of the Precision Public Health Asia Society, board member and fundraising committee chair of TalenTtrust, member of the United Women Singapore STEM Advisory Panel, and board committee member of SATA CommHealth.
Dr Hsien Hsien Lei
Chief Executive Officer
The American Chamber of Commerce in Singapore
Prof Iain Tan Bee Huat
Deputy Group Chief Medical Informatics Officer (Research)
Office of DGCMIO (R)
SingHealth
A/Prof Iain Tan is the Deputy Group Chief Medical Informatics Officer (Research) for DGCIMIO (R), Singhealth. He supports GCMIO in advancing research informatics and accelerating the planning and implementation of clinical information systems, along with professional training and the development of clinical healthcare informatics staff to enhance clinical research activities. Additionally, he plays a crucial role in policy development and in overseeing the governance of clinical data within research. A firm believer in team science, together with his partners, he has published widely in top journals (e.g., Nature, Nature Genetics, JAMA, Cancer Discovery) in CRC, public health, and data science.
Prof Iain Tan Bee Huat
Deputy Group Chief Medical Informatics Officer (Research)
Office of DGCMIO (R)
SingHealth
Dr Jeffrey Goldberg
Professor and Chair of Ophthalmology
Byers Eye Institute at Stanford University
Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University, and a member of the National Academy of Medicine. His research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his laboratory is developing novel molecular, stem cell and nanotherapeutics approaches for eye repair. Dr. Goldberg received his B.S. magna cum laude from Yale , and his M.D. and Ph.D. from Stanford University. He did his clinical training in ophthalmology and glaucoma at Bascom Palmer Eye Institute. He has developed significant expertise with biomarker development and implementing FDA clinical trials for optic nerve neuroprotection and regeneration. His goal is to translate scientific discoveries to patient therapies.
Dr Jeffrey Goldberg
Professor and Chair of Ophthalmology
Byers Eye Institute at Stanford University
Assoc Prof Jeremy Lim’s primary role is as CEO and Co-Founder of AMILI, a microbiome insights company based in Singapore serving the region. Beyond this, he also undertakes academic and practice-focused work in health financing.
Other than AMILI, he is adjunct faculty with Saw Swee Hock School of Public Health, National University of Singapore and Monash University Malaysia.
Outside academia, Jeremy serves on the boards of various for-profit and not-for-profit organizations in different aspects of healthcare including migrant worker health, healthy longevity and digital health interventions. He is a Senior Advisor to the consulting firm, Boston Consulting Group, focusing mainly on healthcare acquisitions and health insurance.
He trained in surgery and public health, attaining post-graduate qualifications in both from the UK and US.
Assoc Prof Jeremy Lim
Chief Executive Officer
AMILI
Jianfei Zhao plays a key role in the editorial operations and strategies, academic conferences, and clinical research training program at Jiahui Medical Research and Education Group in China. He has collaborated with editors and other functions from the NEJM Group for numerous projects, including the annual AI in Medicine Symposium. Previously, he was a scientific editor at Nature Communications. He earned a BSc from Peking University and a PhD in molecular biology from the University of Oregon. He completed his postdoctoral training at the U.S. National Cancer Institute.
Dr Jianfei Zhao
Deputy Editor
NEJM AI
NEJM Group
Professor John Lim is founding Executive Director of the Duke-NUS Centre of Regulatory Excellence, Chairman of the Consortium for Clinical Research & Innovation Singapore, MOH Senior Advisor, and Policy Lead at the SingHealth Duke-NUS Global Health Institute. Formerly CEO of Singapore’s Health Sciences Authority and Deputy Director of Medical Services in MOH, he has also held other senior positions in Singapore’s Health and Education ministries. His current roles promote Asia-Pacific capacity building, scientific excellence, and health regulatory innovation. He chairs the US Pharmacopeia’s Asia-Pacific Chapter and sits on the Singapore Food Agency Board and Singapore Medical Council, among others.
Prof John CW Lim
Executive Director
Centre of Regulatory Excellence
Duke-NUS Medical School
Dr Jolene Ooi
Partner
Investments
EDBI
Dr Jolene Ooi is currently a Partner at EDBI, a Singapore-based global investor in select high growth technology sectors and key strategic industries. In her role with the Healthcare investment team, Jolene leads strategic investments into biotech, medtech and digital health companies. Her past investments include companies developing next-generation therapeutic modalities and precision medicines, such as ElevateBio, Moderna, Nuevocor, Engine Bio, and Hummingbird Bioscience. Prior to joining EDBI, Jolene was a postdoctoral fellow at the Agency for Science, Technology and Research (A*STAR), where she created a comprehensive stem cell repository using gene editing tools to study Huntington Disease. Before that, she pursued a PhD in Molecular Biology at the Wellcome Trust Sanger Institute, University of Cambridge, where she discovered novel targets which were critical in stem cell biology.
Dr Jolene Ooi
Partner
Investments
EDBI
Prof Jonty Heaversedge
Clinical Director & Chief Clinical Informatics Officer
Population Health Office
National Healthcare Group
Jonty is Clinical Director, Population Health Office, National Healthcare Group, Singapore. He is also Director of The Health and Social Change Academy within the Centre for Healthcare Innovation, and Adjunct Professor for Clinical Studies at Lee Kong Chian School of Medicine. In his current role he is tasked with establishing data driven Population Health Management approaches to drive innovation and improvement in care, optimise population outcomes in north and central Singapore, and enhance equity of access to services for local residents. He is also co-Director for the Health Empowered by AI Launchpad in NHG – supporting the adoption of AI capabilities at scale across NHG institutions
Prof Jonty Heaversedge
Clinical Director & Chief Clinical Informatics Officer
Population Health Office
National Healthcare Group
Prof Joseph Sung
Senior Vice President
Health and Life Sciences
Nanyang Technological University Singapore
Prof Sung received his medical degree (MBBS) from The University of Hong Kong, and conferred PhD in biomedical sciences by the University of Calgary and MD by The Chinese University of Hong Kong.
He holds fellowships from multiple organisations worldwide including the Royal Colleges of Physicians of Edinburgh, Glasgow, London, and Australia, the American College of Gastroenterology, the Hong Kong College of Physicians, Japan Gastroenterological Endoscopy Society and Academy of Medicine, Singapore.
He has published over 1000 full scientific articles in leading medical and scientific journals and was listed as “Highly Cited Researchers” from 2018 to 2022 by Clarivate Analytics.
Prof Joseph Sung
Senior Vice President
Health and Life Sciences
Nanyang Technological University Singapore
Dr. Ke Yu He is an Associate Consultant in the Department of Anesthesiology and Perioperative Science at Singapore General Hospital and a Duke-NUS PhD candidate in Clinical and Translational Science. As an A*STAR scholar, she integrates clinical expertise with data science, focusing on large language model, big data analytics, and AI-driven innovations. She is passionate about advancing healthcare efficiency and patient outcomes, and aims to bridge medicine and technology, driving impactful research to shape the future of healthcare delivery and policy.
Dr Ke Yuhe
Associate Consultant
Department of Anaesthesia and Perioperative Science
SingHealth
So Cheer is currently a Partner with PwC leading the Digital Solutions practice where he guides clients in defining and designing Digital and Technology strategies and manages overall program for clients, typically comprising multiple downstream efforts to realize the strategies.
Mr Kwek So Cheer
Partner
Digital Solutions
PwC Singapore
Mr Lee Suen Ming
Chief Executive Officer
Senior Management
Thomson Medical Centre
Mr Lee has been CEO of Thomson Medical Singapore since 1 Nov 2023.
Over the past ten years, Mr Lee held CEO positions at Mount Alvernia Hospital, Gleneagles Hospital, Parkway East Hospital, and Dr Soliman Fakeeh Hospital in Saudi Arabia. He had also served nine years in public healthcare.
Besides the healthcare sector, Mr Lee was with DBS Bank (including a stint as General Manager at DBS LA). In addition, he had a strategic investments role at Singapore Power.
At the national level, Mr Lee was a Management Committee member for Singapore Quality Award. Now he serves as Vice Chairperson of Temasek Junior College’s Advisory Committee, and as Deputy Chairperson of the Technical Committee for Healthcare and Health Informatics, under Enterprise Singapore’s Biomedical & Health Standards Committee.
Mr Lee holds an MBA and a First Class Honours in Electrical and Electronic Engineering.
Mr Lee Suen Ming
Chief Executive Officer
Senior Management
Thomson Medical Centre
Dr Lili Qiu
Assistant Managing Director
Shanghai
Microsoft Research Asia
Dr. Lili Qiu is Assistant Managing Director of Microsoft Research Asia (MSRA) and is mainly responsible for overseeing the research, as well as the collaboration with industries, universities, and research institutes, at Microsoft Research Asia – Shanghai. She obtained her MS and PhD degrees in computer science from Cornell University. Dr. Qiu is an expert in Internet and wireless networking. In 2005, she joined the University of Texas at Austin as an Assistant Professor and later promoted to Full Professor. She joined MSRA in 2022. Dr. Qiu is an IEEE Fellow, a NAI Fellow and an ACM Fellow and also serves as the ACM SIGMOBILE chair. She was named an ACM Distinguished Scientist and was a recipient of the NSF CAREER award, among many other honors.
Dr Lili Qiu
Assistant Managing Director
Shanghai
Microsoft Research Asia
Dr. Nan Liu directs the Duke-NUS AI + Medical Sciences Initiative (DAISI) and leads the Digital Medicine Lab at Duke-NUS Medical School. His research focuses on ethical and trustworthy AI with applications in healthcare and medicine. Dr. Liu has been awarded research grants from the National Medical Research Council and the National Research Foundation. He was recognized as one of the World’s Top 2% Scientists by Stanford University and Elsevier. Dr. Liu has served as an editor for many leading journals, such as npj Digital Medicine and PLOS Medicine.
Assoc Prof Liu Nan
Director
Duke-NUS AI + Medical Sciences Initiative (DAISI)
Duke-NUS Medical School
Dr Liu Yong
Deputy Department Director
Computing and Intelligence
A*STAR Insitute of High Performance Computing
Dr. Liu Yong is Deputy Department Director, Computing & Intelligence Department at Institute of High Performance Computing (IHPC), A*STAR, Singapore. He is also Adjunct Associate Professor at Duke-NUS Medical School, NUS and Adjunct Principal Investigator at Singapore Eye Research Institute (SERI). He has led multiple research projects in multimodal machine learning, medical imaging analysis, especially AI for digital ophthalmology. He has been awarded large scale programme and multiple grants as PI in the area of AI for healthcare. He and his team have been awarded grants from AI SG, NMRC, IAF-PP, and NHIC. He and his team have also published top tier papers in New England Journal of Medicine, Lancet Digital Health, Nature Aging, Ophthalmology, Neurology, Annals of Neurology, and also top-tier AI papers (AAAI, ICLR, CVPR). He has won the Nation Award (Covid-19) Commendation Medal.
Dr Liu Yong
Deputy Department Director
Computing and Intelligence
A*STAR Institute of High Performance Computing
I am a cardiologist clinician scientist with a background in medical physics, cardiac risk assessment, cardiac imaging and AI. I am the founder-director of the CVS.AI research lab. My work aims to harness AI to deepen our understanding of cardiovascular disease and formulate real-world solutions, by providing personalised risk prediction and targeted preventative solutions that will impact patients’ lives.
Clin Asst Prof Lohendran Baskaran (Logen)
Director
CVS.AI Lab
National Heart Centre Singapore
Asst Prof Lua Rui Ping
Director
Technology and Capability
Ministry of Digital Development and Information
Rui Ping is currently the Director of Technology and Capabilities in the Ministry of Digital Development. He oversees policies pertaining to the development of engineering, resiliency and security development for digital government.
Asst Prof Lua Rui Ping
Director
Technology and Capability
Ministry of Digital Development and Information
Assoc Prof Marcus Ang Han Nian
Head & Senior Consultant
Corneal & External Eye Disease, Refractive Services
Singapore National Eye Centre
A/Prof Marcus Ang, is the Head & Senior Consultant of Corneal & External Eye Disease and Refractive Surgery Departments at Singapore National Eye Centre (SNEC). He was rewarded Dean’s List at NUS, and the Best Houseman Award followed by Best Registrar Award in his early clinical practice. He was appointed Fellow of the Roayl College of Surgeons of Edinburgh, and Fellow of the Academy of Medicine, Singapore (FAMS) after being awarded with four FAMS Gold Medals. He further developed his clinical specialty in Cornea Transplantation and was rewarded with a Honorary Consultant position at the prestigious Moorfields Eye Hospital in London, UK. He recently attained his PhD in Ophthalmology with a focus on corneal imaging.
Assoc Prof Marcus Ang Han Nian
Head & Senior Consultant
Corneal & External Eye Disease, Refractive Services
Singapore National Eye Centre
Melvin is the Regional Sales Director for Healthcare at ST Engineering, responsible for expanding into new international markets. He previously served as Deputy Director of Clinical Informatics at the National Healthcare Group, contributing to Singapore’s shift towards patient-centric care and multi-disciplinary management of chronic diseases. He was also part of the team for the Next-Generation Electronic Medical Record (NGEMR) program. With over 13 years in management roles at IBM and CSC in service delivery, transformation, and account management, Melvin has experience in the public, transportation, and healthcare sectors, as well as defense systems development at ST Engineering.
Mr Melvin Ong
Regional Sales Director
Enterprise Digital
ST Engineering
Prof Mohan Kankanhalli
Director
NUS Artificial Intelligence Institute
National University of Singapore
Mohan Kankanhalli is Provost’s Chair Professor of Computer Science at the National University of Singapore (NUS), where he is the Director of the NUS AI Institute. He is also the Deputy Executive Chairman of AI Singapore, which is Singapore’s National AI R&D Program. Mohan obtained his BTech from IIT Kharagpur and MS & PhD from the Rensselaer Polytechnic Institute. Mohan’s research interests are in Multimodal Computing, Computer Vision, and Trustworthy AI. Mohan was a member of World Economic Forum’s Global Future Council on the Future of Artificial Intelligence during 2023-2024. He is a Fellow of IEEE, SNAS, IAPR and ACM.
Prof Mohan Kankanhalli
Director
NUS Artificial Intelligence Institute
National University of Singapore
Dr. Naqi Khan, MD, MS currently serves as the Global Physician Leader for AI & Machine Learning at Amazon Web Services. Previously, he was Principal Program Lead for Health AI at Microsoft, where he launched a new biomedical natural language processing platform. Prior to Microsoft, he led clinical AI projects at Kaiser Permanente (KP), helping develop KP’s machine learning strategy for virtualized care. Dr. Khan completed his Emergency Medicine residency at New York Methodist, holds an M.D. from Stony Brook University, an M.S. in Biomedical Informatics from Vanderbilt University, and a B.S. in Biology and Information Science from Cornell University.
Dr Naqi Khan
Physician Leader, AI & ML
Global Healthcare Industry Solutions
Amazon Web Services
Adj Prof Ngiam Kee Yuan
Head
AI Office
National University Health System
Professor Ngiam Kee Yuan is a clinician scientist with 135 publications and 4224 citations, ranging from clinical science to artificial intelligence. He was awarded the NMRC CIDA award in 2021, which resulted in the development of new AI tools, a patent, and high impact publications in Lancet Oncology [IF 36.418, citied 1041 times] and Nature Digital medicine [IF=15.2]. He is among the world’s top 2% of highly-cited researchers by Stanford University-Elsevier survey in 2023. He is a recipient of multiple grants including the Ministry of Health Innovation grant, HOIC Enterprise Singapore grant, and the Infocomm Media Development Authority (IMDA) 5G grant. He holds multiple patents in surgery and AI technology.
Adj Prof Ngiam Kee Yuan
Head
AI Office
National University Health System
Dr. Nigam Shah is Professor of Medicine at Stanford University, and Chief Data Scientist for Stanford Health Care. His research is focused on bringing AI into clinical use, safely, ethically and cost-effectively. Dr. Shah is an inventor on eight patents, has authored over 300 scientific publications, and has co-founded three companies. Dr. Shah was inducted into the American College of Medical Informatics (ACMI) in 2015 and the American Society for Clinical Investigation (ASCI) in 2016. He holds an MBBS from Baroda Medical College, India, a PhD from Penn State University and completed postdoctoral training at Stanford University.
Prof Nigam Shah
Chief Data Scientist
Stanford Health Care
Prof Patrick Tan
Senior Vice Dean, Research
Office of Research
Duke-NUS Medical School
Prof. Patrick Tan is Senior Vice Dean (Research) at Duke-NUS Medical School Singapore and Executive Director of PRECISE (Precision Health Research Singapore) coordinating Singapore’s National Precision Medicine program. He is also Chief Scientific Officer at the Genome Institute of Singapore, Senior Scientific Advisor (Group Research) at SingHealth and Professor (adjunct) at Duke University, USA. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader. He is an elected member of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, Board of Editors for Science and Cancer Discovery, and on advisory committees for Qatar Precision Health Institute, and Riyadh Biotech City (Saudi Arabia).
Prof Patrick Tan
Senior Vice Dean, Research
Office of Research
Duke-NUS Medical School
Paul Skaria is a Solution Architect Leader for HPC and Cloud at AMD Singapore for APJ region. He has extensive experience in designing and implementing large scale HPC systems across the region. In his current role he is helping customers building the best solutions for on-perm and cloud workloads with AMD technologies. He holds an MBA and a Master’s Degree in Electronics.
Mr Paul Skaria
Solution Architect Leader – ASEAN
AMD
Dr Pavitra Krishnaswamy
Deputy Head
Healthcare and Medtech Division
A*STAR Institute for Infocomm Research
Pavitra Krishnaswamy is a Principal Scientist and Deputy Division Head at the Institute for Infocomm Research, A*STAR, Singapore. She leads an R&D portfolio interfacing real-world data, advanced machine learning and health intelligence. Her team’s innovations in digital phenotyping, risk prediction, and treatment optimization have led to translational outcomes in chronic disease management, population health and precision medicine. She serves on expert committees shaping ethics, regulatory and translational considerations for AI in healthcare. She earned her PhD from the Harvard-MIT Division of Health Sciences and Technology and completed postdoctoral training at MIT. She is on the Singapore 100 Women in Technology List and is a Fellow of the American Medical Informatics Association.
Dr Pavitra Krishnaswamy
Deputy Head
Healthcare and Medtech Division
A*STAR Institute for Infocomm Research
Adj Prof Raymond Chua
Chief Executive Officer
Health Sciences Authority, Singapore
Adj Prof (Dr) Raymond Chua is the Chief Executive Officer-Designate of the Health Sciences Authority responsible for safeguarding and advancing public health through securing the national blood supply, administering national justice through its forensic medicine and scientific testing capabilities and regulating the health products. He is also the Deputy Director-General of Health (Health Regulation) at the Ministry of Health overseeing the regulations of healthcare services and information. With these 2 concurrent positions, he will better synergise regulatory policies, operations and enforcement across healthcare services, information and products in Singapore. He has extensive regulatory, management and operational experience in both the public healthcare and private pharmaceutical sectors in the past 25 years, contributing to the advancing developments of the healthcare landscape.
Adj Prof Raymond Chua
Chief Executive Officer
Health Sciences Authority, Singapore
Prof Robert JT Morris
Chief Technology Strategist
Data, Science and Technology
Ministry of Health Office for Healthcare Trasnformation
Prof Robert JT Morris is Chief Technology Strategist for the Ministry of Health Office for Healthcare Transformation (MOHT) Singapore and concurrently Professor, National University of Singapore Yong Loo Lin School of Medicine. His team deploys computer science and AI-based solutions for chronic diseases and mental health. Previously, he led all IBM Research’s Global Laboratories, including Australia, Africa, China, India, Japan, Singapore and South America. Earlier, he led Personal Systems and Advanced Systems Research at IBM TJ Watson Research Center, and headed the IBM Almaden Research Center, Silicon Valley. Concurrently, he chaired the Bay Area Science and Innovation Consortium consisting of all Universities and Research Labs in the San Francisco Bay Area.
Prof Robert JT Morris
Chief Technology Strategist
Data, Science and Technology
Ministry of Health Office for Healthcare Transformation
Dr. Rupa Sarkar is the founding Editor-in-Chief of The Lancet Digital Health. Since her appointment in November 2018, The Lancet Digital Health is the leading journal in the field of artificial intelligence (AI) and digital health, with a mission to advance standards for the next generation of health care technology.
Rupa is an experienced editor and scientist working across a broad range of subject areas. She has delivered seminars at over 30 conferences in the USA, China, Singapore, India, Europe, and UK. Her interests span all interdisciplinary areas of digital health, with a particular interest in genomics and AI in clinical applications. Rupa obtained her Ph.D. in embryonic stem cell development from Imperial College London, U.K. After her postdoctoral research at the Albert Einstein College of Medicine, NY, USA, Rupa joined the Nature Research Group. Prior to her appointment at The Lancet Digital Health, Rupa was the Chief Editor of Nature Protocols.
Dr Rupa Sarkar
Editor-in-Chief
The Lancet Digital Health
The Lancet Group
Dr Sebastian Maurer-Stroh
Executive Director
A*STAR Bioinformatics Institute
He studied theoretical biochemistry at the University of Vienna and wrote his master and PhD thesis at the Institute of Molecular Pathology. After FEBS and Marie Curie fellowships at the VIB-SWITCH lab in Brussels, he has been leading the sequence analytics portfolio in the A*STAR Bioinformatics Institute (BII) since 2007 and Infectious Disease Programme since 2010. He is the Executive Director of BII since Jan 2021. His computational team is well known for successes at the public-private interface in Singapore from Precision Medicine to Consumer Product and Food Safety and of course for his critical contributions to national and global viral pathogen surveillance through the GISAID data science initiative that has become the single most important source for virus outbreak data sharing and analysis in this pandemic powering public health responses globally.
Dr Sebastian Maurer-Stroh
Executive Director
A*STAR Bioinformatics Institute
Sebastian Togelang is a seasoned entrepreneur, investor, and fund manager with 25+ years of experience. He founded his first business at 19 and built multiple tech companies into international successes. His funds ranked top 10 globally (Preqin). Founder of Rigel Capital, previously co-founded Kejora Capital ($700M AUM, 4 unicorns), and co-founder of FinTech Association Indonesia. Investments created 150,000+ jobs. He co-founded or invested in companies such as Volta Electric Vehicle, Metalbook, and Amilo, Sicepat Express, DMMX, MCASH, Qareer group, Finfleet. Alumni of Deutsche Bank, Deutsche Boerse, and Johann Wolfgang University.
Mr Sebastian Togelang
Founder & Managing Partner
Rigel Capital
Dr Sha Yu
Senior Editor
Cell Press
Cell Reports Medicine
Dr. Sha Yu received her PhD in Genetics from the University of Chinese Academy of Sciences. Her postdoctoral research at Seoul National University focused on microRNAs and RNA modifications. Sha joined Cell Press in 2020, and she is a senior editor at Cell Reports Medicine. Sha handles papers on digital health, oncology, stem cells, bioengineering, and neurology. In 2021, Cell Press initiated the “Multi-Journal Submission” model. Sha also serves as a consulting editor for “Multi-Journal Submission” at Cell Press.
Dr Sha Yu
Senior Editor
Cell Press
Cell Reports Medicine
Mr Sim Feng-Ji
Deputy Secretary
Digital Government
Ministry of Digital Development and Information
Mr Sim Feng-ji is the Deputy Secretary (Digital Government) of Singapore’s Ministry of Digital Development and Information (MDDI). He oversees efforts to transform Singapore and Digital Government to harness technology to effect transformation in government services, businesses, health, transport, and urban living. Previously, he oversaw Income Security Policy at the Ministry of Manpower. Mr Sim has contributed to various economic and social policy reviews, including the Committee on the Future Economy. He has held positions in multiple ministries, including Trade and Industry, Home Affairs, and Finance. Sim holds degrees from the University of Cambridge (MA Economics) and MIT (MBA, MSc Political Science).
Mr Sim Feng-Ji
Deputy Secretary
Digital Government
Ministry of Digital Development and Information
Ban Leong is the Head and Senior Consultant at the Department of Women’s Anaesthesia, Chief Data and Digital Officer and Deputy Campus Director of the Digital Integration Medical Innovation and Care Transformation Office at KK Women’s and Children’s Hospital. His academic interest includes research and innovations in obstetric anaesthesia and analgesia, artificial intelligence, pain and psychological vulnerability.
Prof Sng Ban Leong
Head and Senior Consultant
Women’s Anaesthesia
KK Women’s and Children’s Hospital
Mrs Stephanie Magazzeni
Head of Digital Research and Innovation
Digital Health
Carl Zeiss Meditec AG
MedTech executive with 20 years of experience in ophthalmology and digital health. As the Head of Digital Research & Innovation at ZEISS Medical Technology, Stephanie plays a pivotal role in the digital transformation of the organization, focusing on AI-based clinical research and fostering strategic partnerships across academia, pharma, and technology sectors to drive innovation in eye care.
Throughout her career, she has successfully led significant projects and contributed to the launch of groundbreaking AI-driven ophthalmic and digital applications, all while maintaining a commitment to making a positive difference in the healthcare landscape.
Mrs Stephanie Magazzeni
Head of Digital Research and Innovation
Digital Health
Carl Zeiss Meditec AG
Stephen Lim is a seasoned executive with over 30 years of experience leading businesses across diverse industries in Asia. He has a proven track record in both public and private sectors, including publicly listed companies on the Singapore Exchange Mainboard. Prior to healthcare, he held leadership positions in food manufacturing, FMCG food distribution, health supplements, and medical device distribution in China. As CEO of Auric Pacific Group’s Food Group, he oversaw Sunshine Bakery and SCS Butter. He also served as CEO of Camsing Healthcare Ltd and was a Senior Vice President at Ascendas-Singbridge Pte Ltd (Temasek Holdings). In recent years, he has focused on healthcare innovation, spearheading Lion TCR Pte Ltd and BioCheetah Pte Ltd. Currently, he is CEO of FathomX Pte Ltd, a NUS medtech spinoff developing AI-powered solutions for medical imaging, focusing on breast cancer.
Mr Stephen Lim
Chief Executive Officer
FathomX Pte Ltd
Dr. Steven Ang is a trained clinician with a career spanning over three decades. Dr. Ang has also consistently lent his expertise to the advancement of national Healthcare IT initiatives for the past 30 years. In 2019, Dr. Ang embraced a pivotal role as a key member of the EyRIS team, where he assumed leadership of the company’s global expansion. EyRIS, has trailblazed AI-driven healthcare technology and established its presence in over 30 countries worldwide. EyRIS’s global outreach have also resulted in the integration of their cutting-edge AI technology into three prominent National Diabetic Retinopathy (DR) Screening Programs across Asia and Middle East.
Dr Steven Ang
Chief Strategy Officer
Business Development
EyRIS Pte Ltd
Steven is a Musculoskeletal Radiologist with interest in Cartilage Imaging. He chairs the SingHealth RISPACS Steering Committee and Co-Chairs the Enterprise Digital Imaging Initiative. He was a previous Chair of the Global Outreach Committee for the Society of Imaging Informatics in Medicine (USA) and remains an active member. He is a firm believer that the Informatics Infrastructure must be robust and inclusive in order for any AI initiative to function.
Assoc Prof Steven Wong
Chair, Division of HyperAcute Care
Radiology
Sengkang General Hospital
Assoc Prof Goh Su-Yen trained in Endocrinology at the Singapore General Hospital and spent her fellowship year in a joint clinical and research program at the Alfred Hospital and the Baker Heart Research Institute in Melbourne, Australia. She was Director, Diabetes Centre from 2006 till 2011, and the Head of Department of Endocrinology from 2011 to 2020. She is currently the Head of the SingHealth Duke-NUS Diabetes Centre and Clinical Director, Future Health Systems SGH.
Assoc Prof Su-Yen Goh
Head
SingHealth-Duke Diabetes Centre
SingHealth
Assoc Prof Tam C. Nguyen
Deputy Director of Research
Research Directorate
St Vincent’s Hospital Melbourne
Tam has 25 years of experience spanning clinical trials, health & medical research and research innovation sector including tertiary teaching hospitals, medical research institutes and universities across Australia.
Tam is responsible for research strategy, research development, innovation and partnership at St Vincent’s. He’s a co-editor of a recent book: AI in Medicine (Springer).
Tam serves as non-executive director & advisor to several medtech and health tech start-ups and scale ups in Australia and across South East Asia. He sits on the investment committee of Horizon 3 Healthcare venture fund.
Assoc Prof Tam C. Nguyen
Deputy Director of Research
Research Directorate
St Vincent’s Hospital Melbourne
Tan Bin Ru is the President of Enterprise Digital at ST Engineering, leading digital transformation initiatives across industries with a focus on AI and healthcare. She advocates for the responsible use of emerging technologies, including blockchain, through her role as Chairwoman of the Blockchain Association of Singapore. With over 25 years of leadership experience, Bin Ru has held senior roles in MNCs and startups, including Deputy CEO of ChainUp and CEO of OneConnect Financial Technology. Her contributions to the Singapore fintech industry have been recognized with multiple awards, including “Top 5 Women in FinTech” and “Woman in FinTech.”
Ms Tan Bin Ru
President
Enterprise Digital
ST Engineering
A/Professor Cher Heng Tan graduated with MBBS (Singapore) and FRCR (UK). He completed his Abdominal Imaging Fellowship at MD Anderson Cancer Center and Executive MBA from Insead. He is presently Senior Consultant with the Department of Diagnostic Radiology at Tan Tock Seng Hospital, where he also serves as Assistant Chairman Medical Board (Clinical Research and Innovation). Cher Heng holds concurrent appointments as Group Chief Research and Innovation Officer, NHG, Assistant Dean (Clinical Research) for Lee Kong Chian School of Medicine and Director of the newly formed Academic Partnerships Office. As co-Chair for the national imaging AI platform (AimSG), he oversees radiology AI model implementation in our public healthcare institutions.
Assoc Prof Tan Cher Heng
Group Chief
Research and Innovation
National Healthcare Group
A/Prof Tan Hiang Khoon is a dynamic healthcare leader shaping the future of hospital systems. As CEO of Singapore General Hospital (SGH)—Singapore’s largest acute tertiary hospital and one of the world’s top academic medical centres—he spearheads a people-centric, digital-first strategy to enhance patient care, system resilience, and sustainability. He champions the convergence of care, research, and innovation to drive breakthroughs in clinical excellence and healthcare transformation. Passionate about advancing health equity in Singapore and Asia, he is committed to redefining hospital models to position SGH as a global leader in health innovation.
Assoc Prof Tan Hiang Khoon
Chief Executive Officer
Singapore General Hospital
Keng Leng has 20 years of experience in AI, mission-critical systems, utilities, and public safety, covering sales, technical, product, and project roles. He specializes in leveraging new technologies to enhance organizational awareness and productivity in these sectors. Currently, he manages presales and solutioning for ST Engineering’s healthcare business, focusing on hospital operations, automation, nursing productivity, and AI applications. His previous experience in AI, computer vision, and deep learning supports his work in developing next-generation intelligent systems, including those powered by Generative AI and other emerging technologies.
Mr Tan Keng Leng
Pre-sales Director
Enterprise Digital
ST Engineering
Prof Tan Sze Wee, is currently the Advisor to Temasek International. Prof Tan’s career spans across public sector, corporate and industry start-ups. He spent more than a decade between a US corporate and biotech start-up. Prof Tan’s career in ASTAR started in 2009 and he spent his time across the Science and Engineering Research Council, Biomedical Research Council as a well as the Innovation and Enterprise Division. Professor Tan has also promoted international research, enterprise partnership between Singapore, AStar and its key scientific international partners. He is a speaker at international conferences and advises academic, corporate and not for profit organisations. Professor Tan is Adjunct Professor at Nanyang Technological University’s (NTU) Lee Kong Chian School of Medicine, as well as an Adjunct Professor at Duke-NUS Medical School Singapore.
Adj Prof Tan Sze Wee
Advisor
Healthcare
Temasek International
Vishal is an entrepreneur turned venture capitalist. He is a Managing Partner at 500 Global, a Silicon Valley based multi-stage VC firm with $3B in assets under management. Vishal has invested in over 300 companies over the past decade, and leads the firm’s strategies in A.I., healthcare among other frontiers. He is a Kauffman Fellow, and his thoughts on technology and humanity have been featured on Bloomberg, CNBC, and The Unreasonable Podcast, where he explores ideas that challenge conventional wisdom. He lives between Singapore, Tokyo and San Francisco.
Mr Vishal Harnal
Managing Partner
500 Global
Prof Wong Tien Yin
Founding Head & Senior Vice-Chancellor
Tsinghua Medicine
Tsinghua University
Prof Wong is a senior academic ophthalmologist and physician-scientist. Prior to current his appointment at Tsinghua University, China, he was Arthur Lim Professor and Medical Director of the Singapore National Eye Center.
Prof Wong is a retinal specialist, with a research portfolio on retinal diseases and ocular imaging, including AI. He has published >1,500 peer-reviewed papers.
Prof Wong has served as a Board member of numerous professional organisations, including the International Council of Ophthalmology and the Asia Pacific Academy of Ophthalmology.
He has been recognised with multiple international awards, including the Alcon Research Institute Award and the ARVO Friedenwald Award.
Prof Wong Tien Yin
Founding Head & Senior Vice-Chancellor
Tsinghua Medicine
Tsinghua University
Mr. Yeong Zee Kin is the Chief Executive of the Singapore Academy of Law, a promotion and development agency for Singapore’s legal profession. A globally recognised expert in AI ethics, he spearheaded Singapore’s Model AI Governance Framework which won the UNITU WSIS Prize in 2019 and was a member of the AI Group of Experts at the OECD (AIGO), which developed the OECD Principles on AI that were endorsed by the G20 in 2019. Zee Kin has tapped on his expertise in various areas of the law to contribute widely to various legal publications, including Data Protection Law in Singapore and Law and Technology in Singapore. He also authored Technology Regulation in the Digital Economy, which was launched at TechLaw.Fest 2023.
Mr Yeong Zee Kin
Chief Executive
Chief Executive’s Office
Singapore Academy of Law
Ms Yvonne Lim
Cluster Director
Asia Tech x Programme Office, Digital Industry Singapore
Infocomm Media Development Authority
Yvonne, Director of Asia Tech x Programme Office and Digital Industry Singapore at IMDA, orchestrates strategic initiatives to advance Singapore’s digital interests. She leads Asia Tech x Singapore, a flagship tech event convening global leaders. At DISG, she fosters the Infocomm and Media sector, encouraging tech companies to develop competitive products for the global market. Leveraging cross-agency expertise, she creates ecosystems that drive new revenue streams and accretive value. Previously, Yvonne was APAC and EMEA Innovation lead for a Fortune Global 500 consulting firm, demonstrating her passion for articulating business value through technology.
Ms Yvonne Lim
Cluster Director
Asia Tech x Programme Office, Digital Industry Singapore
Infocomm Media Development Authority
A/Prof Zhong Liang is a Senior Clinician-Innovator, Principal Investigator at National Heart Research Institute Singapore, Associate Professor at Duke-NUS Medical School Singapore and Department of Biomedical Engineering, National University of Singapore. He is the director of College of Healthcare Engineering, SingHealth Duke-NUS AMC, and the founding technical lead of cardiovascular systems imaging and artificial intelligence (CVS.AI) lab. A/Prof. Zhong has broad research portfolio on cardiovascular imaging with artificial intelligence, digital twins, multiscale computational modelling and simulation. He has published over 180 peer-reviewed papers and filed over 12 patents. Professor Zhong spearheads the APOLLO program, dedicated to automating the diagnosis of coronary artery disease through AI-enhanced CT angiography.
Assoc Prof Zhong Liang
Director
College of Healthcare Engineering
SingHealth Duke-NUS AMC